Asparagine-linked glycosylation of the scrapie and cellular prion proteins

https://doi.org/10.1016/0003-9861(89)90409-8Get rights and content

Abstract

Post-translational modification of the scrapie prion protein (PrP) is thought to account for the unusual features of this protein. Molecular cloning of a PrP cDNA identified two potential Asn-linked glycosylation sites. Both the scrapie (PrPSc) and cellular (PrPC) isoforms were susceptible to digestion by peptide N-glycosidase F (PNGase F) but resistant to endoglycosidase H as measured by migration in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. PNGase F digestion of PrPC yielded two proteins of Mr 26K and 28K; however, the 26-k species was only a minor component. In contrast, PNGase F digestion of PrPSc yielded equimolar amounts of two proteins of Mr 26K and 28K. The significance of this altered stoichiometry between the 26- and 28-kDa deglycosylated forms of PrP during scrapie infection remains to be established. Both isoforms as well as PrP 27–30, which is produced by limited proteolysis of PrPSc, exhibited a reduced number of charge isomers after PNGase F digestion. The molecular weight of PrP 27–30 was reduced from 27K–30K by PNGase F digestion to 20K–22K while anhydrous hydrogen fluoride or trifluoromethanesulfonic acid treatment reduced the molecular weight to 19K–21K and 20K–22K, respectively. Denatured PrP 27–30 was radioiodinated and then assessed for its binding to lectin columns. PrP 27–30 was bound to wheat germ agglutinin (WGA) or lentil lectins and eluted with N-acetylglucosamine or α-melthylmannoside, respectively. Digestion of PrP 27–30 with sialidase prevented its binding to WGA but enhanced its binding to Ricinus communis lectin. These findings argue that PrP 27–30 probably possesses Asn-linked, complex oligosaccharides with terminal sialic acids, penultimate galactoses, and fucose residues attached to the innermost N-acetyl-glucosamine. Whether differences in Asn-linked oligosaccharide structure between PrPC and PrPSc exist and are responsible for the distinct properties displayed by these two isoforms remain to be established.

References (47)

  • B. Oesch et al.

    Cell

    (1985)
  • K. Basler et al.

    Cell

    (1986)
  • N. Stahl et al.

    Cell

    (1987)
  • S.B. Prusiner et al.

    Cell

    (1983)
  • A.S.B. Edge et al.

    Anal. Biochem

    (1981)
  • A.J. Mort et al.

    Anal. Biochem

    (1977)
  • P.Z. O'Farrell et al.

    Cell

    (1977)
  • S. Olofsson et al.

    Virology

    (1985)
  • D. Ochs

    Anal. Biochem

    (1983)
  • T. Marshall et al.

    Anal. Biochem

    (1984)
  • C. Bordier

    Cell

    (1981)
  • I.J. Goldstein et al.
  • T.H. Plummer et al.

    J. Biol. Chem

    (1963)
  • A. Tarentino et al.

    J. Biol. Chem

    (1970)
  • R.D. Cummings et al.

    J. Biol. Chem

    (1982)
  • G.D. Hunter et al.

    J. Comp. Pathol

    (1973)
  • S.B. Prusiner

    N. Engl. J. Med

    (1987)
  • R.K. Meyer et al.
  • N. Stahl et al.

    FASEB J

    (1988)
  • B. Chesebro et al.

    Nature (London)

    (1985)
  • D.C. Bolton et al.

    J. Virol

    (1985)
  • B. Hay et al.

    Mol. Cell. Biol

    (1987)
  • Cited by (202)

    • The role of membranes in function and dysfunction of intrinsically disordered amyloidogenic proteins

      2022, Advances in Protein Chemistry and Structural Biology
      Citation Excerpt :

      These two domains are connected by a conserved hydrophobic core (HC) region (residues 105–126) that make contacts with the biological membrane. PrPc can be glycosylated at two highly conserved amino acid positions (N180 and N196 in mice) and form diglycosylated, monoglycosylated at N180, monoglycosylated at N196, and unglycosylated PrPc (Haraguchi et al., 1989). Prions are attached to the membrane by a glycosyl-phosphatidyl inositol (GPI) anchor.

    • Treatment of microglia with Anti-PrP monoclonal antibodies induces neuronal apoptosis in vitro

      2021, Heliyon
      Citation Excerpt :

      Prion diseases are a group of fatal neurodegenerative diseases characterized by the conversion of the α-helices-rich cellular prion protein, PrPC and deposition in the central nervous system (CNS) of humans and animals of a disease specific isoform, PrPSc that is rich in β-sheet structure and partially proteinase-resistant (Prusiner and DeArmond, 1994; Tayebi and Hawke, 2006). The majority of PrP molecules carry bi-, tri- and tetra-antennary neutral and N-linked sialylated oligosaccharides at two sites (Endo et al., 1989; Haraguchi et al., 1989). A disulfide bond links the only two cysteines in the mature prion protein (Turk et al., 1988).

    • Multisite interactions of prions with membranes and native nanodiscs

      2021, Chemistry and Physics of Lipids
      Citation Excerpt :

      Smaller amounts of two alternative topologic forms called Ntm- and Ctm-PrP can be generated within the biosynthetic pathway of the ER; they share the same membrane spanning region derived from PrP's central tract of hydrophobic residues, but they are oriented in opposite ways (Yost et al., 1990). Two asparagine residues are the sites of addition of heterogeneous antennary glycosyl structures (Haraguchi et al., 1989). A further form of PrP is shed from cell, resulting from the action of ADAM10, a metalloprotease sheddase.

    • Neurodegeneration meets immunology – A chemical biology perspective

      2019, Bioorganic and Medicinal Chemistry
      Citation Excerpt :

      Two main N-glycoforms of PrP exist, mono- and di-glycosylated PrP. Haraguchi and coworkers laid the foundation for characterizing the glycosylation pattern of PrPC and PrPSc via treating purified PrP with N-glycosidase F.176 Subsequent publications using combinations of biochemical methods and mass spectrometry by two different groups showed that N-glycoforms of PrP are highly heterogeneous.177,178 Over 50 glycoforms of PrPC and PrPSc could be characterized with an increased number of tri- and tetra-antennary glycans found on PrPSc using hydrazinolysis, fluorescence labeling or acetylation of glycans and glycosidase digestion followed by mass spectrometry.

    View all citing articles on Scopus

    This work was supported by research grants from the National Institutes of Health (AG02132 and NS14069), the Senator Jacob Javits Center of Excellence in Neuroscience (NS22786), the Swedish Medical Research Council (4515), and the State of California, Department of Health Services (8792062), as well as by gifts from the Sherman Fairchild Foundation and RJR/Nabisco, Inc.

    View full text